Cargando…

Transient trimethylaminuria related to menstruation

BACKGROUND: Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylam...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Makiko, Cashman, John R, Yamazaki, Hiroshi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790885/
https://www.ncbi.nlm.nih.gov/pubmed/17257434
http://dx.doi.org/10.1186/1471-2350-8-2
_version_ 1782132131160391680
author Shimizu, Makiko
Cashman, John R
Yamazaki, Hiroshi
author_facet Shimizu, Makiko
Cashman, John R
Yamazaki, Hiroshi
author_sort Shimizu, Makiko
collection PubMed
description BACKGROUND: Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3). METHODS: FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine N-oxide) was defined as the urinary ratio of trimethylamine N-oxide to total trimethylamine. RESULTS: Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] FMO3 polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing < 40% metabolic capacity. In comparison, three healthy control subjects that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] FMO3 or homozygous for wild FMO3 showed normal (> 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60–70%. CONCLUSION: Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function.
format Text
id pubmed-1790885
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-17908852007-02-03 Transient trimethylaminuria related to menstruation Shimizu, Makiko Cashman, John R Yamazaki, Hiroshi BMC Med Genet Research Article BACKGROUND: Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3). METHODS: FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine N-oxide) was defined as the urinary ratio of trimethylamine N-oxide to total trimethylamine. RESULTS: Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] FMO3 polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing < 40% metabolic capacity. In comparison, three healthy control subjects that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] FMO3 or homozygous for wild FMO3 showed normal (> 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60–70%. CONCLUSION: Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function. BioMed Central 2007-01-27 /pmc/articles/PMC1790885/ /pubmed/17257434 http://dx.doi.org/10.1186/1471-2350-8-2 Text en Copyright © 2007 Shimizu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shimizu, Makiko
Cashman, John R
Yamazaki, Hiroshi
Transient trimethylaminuria related to menstruation
title Transient trimethylaminuria related to menstruation
title_full Transient trimethylaminuria related to menstruation
title_fullStr Transient trimethylaminuria related to menstruation
title_full_unstemmed Transient trimethylaminuria related to menstruation
title_short Transient trimethylaminuria related to menstruation
title_sort transient trimethylaminuria related to menstruation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790885/
https://www.ncbi.nlm.nih.gov/pubmed/17257434
http://dx.doi.org/10.1186/1471-2350-8-2
work_keys_str_mv AT shimizumakiko transienttrimethylaminuriarelatedtomenstruation
AT cashmanjohnr transienttrimethylaminuriarelatedtomenstruation
AT yamazakihiroshi transienttrimethylaminuriarelatedtomenstruation